Literature DB >> 28315260

Introduction to Sigma Receptors: Their Role in Disease and as Therapeutic Targets.

Sylvia B Smith1.   

Abstract

This book highlights contributions from leaders in the field of sigma receptor research. Sigma receptors represent a promising, novel target for the treatment of neurodegenerative diseases, retinal degenerations, pain and substance abuse. Information is presented about tracers for molecular imaging these receptors, the newly determined crystal structure of human sigma 1 receptor and information about sigma 2 receptor. New discoveries about the role of sigma 1 receptors in cancer, pain, neuropsychiatric disorders, learning and memory, neuronal networks and depression are described. The compendium offers important insights about the direction unfolding for this exciting field of research.

Entities:  

Keywords:  Alcoholism; Amyotrophic lateral sclerosis; Crystal structure sigma receptor; Drug addiction; Neuronal degeneration; Neuroprotection; Pain; Retinal degeneration; Sigma receptor; Substance abuse; Therapeutic target

Mesh:

Substances:

Year:  2017        PMID: 28315260     DOI: 10.1007/978-3-319-50174-1_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

1.  Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents.

Authors:  Silvia Franchini; Pasquale Linciano; Giulia Puja; Annalisa Tait; Chiara Borsari; Nunzio Denora; Rosa Maria Iacobazzi; Livio Brasili; Claudia Sorbi
Journal:  ACS Med Chem Lett       Date:  2020-04-03       Impact factor: 4.345

2.  New analogs of SYA013 as sigma-2 ligands with anticancer activity.

Authors:  Gladys Asong; Xue Y Zhu; Barbara Bricker; Terrick Andey; Felix Amissah; Nazarius Lamango; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2019-04-08       Impact factor: 3.641

3.  Generation of Sigmar1 conditional knockout mouse using CRISPR-Cas9 gene targeting.

Authors:  Liang Huang; Haiyan Xiao; Xiaoling Xie; Fang Hu; Fulei Tang; Sylvia B Smith; Lin Gan
Journal:  Genesis       Date:  2022-05-28       Impact factor: 2.389

Review 4.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

5.  Benzimidazolone-based selective σ2 receptor ligands: Synthesis and pharmacological evaluation.

Authors:  Sebastiano Intagliata; Walid F Alsharif; Christophe Mesangeau; Nicola Fazio; Michael Seminerio; Yan-Tong Xu; Rae R Matsumoto; Christopher R McCurdy
Journal:  Eur J Med Chem       Date:  2019-01-09       Impact factor: 6.514

Review 6.  The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.

Authors:  Botond Penke; Livia Fulop; Maria Szucs; Ede Frecska
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

7.  Structural Insights into σ₁ Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations.

Authors:  Mateusz Kurciński; Małgorzata Jarończyk; Piotr F J Lipiński; Jan Cz Dobrowolski; Joanna Sadlej
Journal:  Molecules       Date:  2018-02-18       Impact factor: 4.411

8.  Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors.

Authors:  Eugen Brailoiu; Sumita Chakraborty; G Cristina Brailoiu; Pingwei Zhao; Jeffrey L Barr; Marc A Ilies; Ellen M Unterwald; Mary E Abood; Colin W Taylor
Journal:  Cell Rep       Date:  2019-01-08       Impact factor: 9.423

9.  Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats.

Authors:  Carlo Cifani; Emanuela Micioni Di Bonaventura; Luca Botticelli; Fabio Del Bello; Gianfabio Giorgioni; Pegi Pavletić; Alessandro Piergentili; Wilma Quaglia; Alessandro Bonifazi; Dirk Schepmann; Bernhard Wünsch; Giulio Vistoli; Maria Vittoria Micioni Di Bonaventura
Journal:  ACS Chem Neurosci       Date:  2020-09-21       Impact factor: 4.418

10.  The Sigma-2 receptor / transmembrane protein 97 (σ2R/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice.

Authors:  Sema G Quadir; Sean M Tanino; Christian D Rohl; James J Sahn; Emily J Yao; Luíza Dos Reis Cruz; Pietro Cottone; Stephen F Martin; Valentina Sabino
Journal:  Neuropharmacology       Date:  2020-11-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.